Seminar: “Current topics in Pharmacology and Theranostics“

Seminar room INO-F 703, Institute of Pharmacology

Date Time Name   Title Host 
Jan 19, 2018  12:15  Prof. Dr. Daniel Hoessli, Panjwani Center for Molecular Medicine and Drug Design, University of Karachi, Pakistan Modulation of resistance to tyrosine kinase inhibitors H.-U. Simon 
Feb 14, 2018 12:15 PD Dr. Remo Perozzo, Senior Lecturer and Research Associate (MER), School of Pharmaceutical Sciences, University of Geneva Development of a novel bacterial three-hybrid system: A feasibility study H.-U. Simon  
Feb 28, 2018 12:15  Dr. Isabelle Arnold, Institute of Molecular Cancer Research, University of Zurich Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation   H.-U. Simon 
Mar 13, 2018 16:00 Prof. Guy Gorochov, Head of Department of Immunology, Co-director, CIMI research centre, Paris, France  Metagenome-wide analysis of gut microbiota in human IgA deficiency  S. von Gunten 
Mar 21, 2018 12:15 Dr. Melita Irving, Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne T-Cell Engineering Approaches for Improving Cancer Immunotherapy  S. von Gunten 
Mar 28, 2018 12:15 Prof. Dr. Jan Hendrik Niess, Universitätsspital Basel, Gastroenterologie und Hepatologie IL-20 Cytokines in Intestinal Diseases H.-U. Simon
April 18, 2018 12:15 Prof. Dr. Richard Cummings, Harvard Medical School, Boston, USA  Glycosylation is Required for Leukocyte Trafficking and Function in Immune Recognition S. von Gunten 
May 16, 2018 12:30  Prof. Csaba Szabo, MD, PhD, D.Sc., Department of Pharmacology, University of Fribourg The vascular roles of H2S in health and disease A. Huwiler
May 30, 2018  12:15  Dr. Christoph Esslinger, CEO Memo Therapeutics AG MemoMAB: Gateway to human antibody repertoires  S. von Gunten  
June 15, 2018 15:00 Prof. Mojgan Masoodi, Adjunct Professor, Departement of Nutritional Sciences, Faculty of Medicine, Univeristy of Toronto, Lipid biology group leader, Nestlé Insitute of Health Sciences, Lausanne, Switzerland  The role of lipid metabolism in metabolic disorders: From biomarker discovery to nutritional intervention  C. Largiadèr
July 18, 2018  12:15 Prof. em. Dr. Urs Rüegg, Department of Pharmacology, University of Geneva Tamoxifen: a potential drug for treatment of Duchenne muscular dystrophy A. Huwiler 
Sep 19, 2018 12:15 Prof. Robbie Joseph Loewith, Department of Molecular Biology, University of Geneva, Switzerland  Growth control by TORC1 and TORC2, opposite sides of the same coin G. Konstantinidou 
Sep 26, 2018 12:15 Dr. Alexander Lämmle, Universitätsklinik für Kinderheilkunde und Universitätsinstitut für Kinische Chemie, Inselspital, University of Bern Liver disease modeling using iPSC-derived hepatocytes H.-U. Simon 
Nov 21, 2018  12:15  Prof. Dr. Edward Pearce, Max Planck Institute of Immunobiology and Epigenetics and University of Freiburg, Freiburg, Germany  Title to be announced  H.-U. Simon
Nov 28, 2018
12:15
Prof. Dr. Inti Zlobec, Institute of Pathology, University of Bern Digital pathology in translational research
S. von Gunten
Feb 8, 2019 12:15  Véronique Witko-Sarsat, PhD, Directeur de Recherche, Institut Cochin, Département Immunologie-Infection-Inflammation, Paris Title to be announced  H.-U. Simon

Spnsored by:

Astellas Pharma AG, Wallisellen

Pfizer AG, Zürich

Other potential sponsors please contact Prof. Simon